The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 02, 2022
Filed:
Oct. 26, 2018
Applicant:
Esteve Pharmaceuticals, S.a., Barcelona, ES;
Inventors:
Carmen Almansa-Rosales, Barcelona, ES;
Félix Cuevas-Cordobés, Valdemoro, ES;
Assignee:
ESTEVE PHARMACEUTICALS, S.A., Barcelona, ES;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); C07D 409/12 (2006.01); C07D 487/02 (2006.01); C07D 487/04 (2006.01); C07D 243/14 (2006.01); C07D 243/08 (2006.01); C07D 223/10 (2006.01); A61P 29/00 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); C07D 223/10 (2013.01); C07D 243/08 (2013.01); C07D 243/14 (2013.01); C07D 409/12 (2013.01); C07D 471/04 (2013.01);
Abstract
The present invention relates to new compounds of formula (I) that show great affinity and activity towards the subunit α2δ of voltage-gated calcium channels (VGCC), or dual activity towards the subunit α2δ of voltage-gated calcium channels (VGCC) and the noradrenaline transporter (NET). The invention is also related to the process for the preparation of said compounds as well as to compositions comprising them, and to their use as medicaments.